Medicare Program; Public Meeting on June 24, 2019 Regarding New and Reconsidered Clinical Diagnostic Laboratory Test Codes for the Clinical Laboratory Fee Schedule for Calendar Year 2020, 12257-12260 [2019-06148]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 62 / Monday, April 1, 2019 / Notices
• The factors used in determining
coverage and payment processes for
new clinical diagnostic laboratory tests.
• Other aspects of the new payment
system under section 1834A of the Act.
A notice announcing the
establishment of the Panel and soliciting
nominations for members was
published in the October 27, 2014
Federal Register (79 FR 63919 through
63920). In the August 7, 2015 Federal
Register (80 FR 47491), we announced
membership appointments to the Panel
along with the first public meeting date
for the Panel, which was held on August
26, 2015. Subsequent meetings of the
Panel were also announced in the
Federal Register.
II. Agenda
The Agenda for the July 22 and 23,
2019 Panel meeting will provide for
discussion and comment on the
following topics as designated in the
Panel’s charter:
• Calendar Year (CY) 2020 Clinical
Laboratory Fee Schedule (CLFS) new
and reconsidered test codes, which will
be posted on the CMS website at https://
www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/ClinicalLab
FeeSched/Laboratory_Public_
Meetings.html.
• Other CY 2020 CLFS issues
designated in the Panel’s charter and
further described on the Agenda.
A detailed Agenda will be posted
approximately 2 weeks before the
meeting, on the CMS website at https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/Advisory
PanelonClinicalDiagnosticLaboratory
Tests.html. The Panel will make
recommendations to the Secretary and
the Administrator of CMS regarding
crosswalking and gapfilling for new and
reconsidered laboratory tests discussed
during the CLFS Annual Public Meeting
for CY 2020. The Panel will also provide
input on other CY 2020 CLFS issues that
are designated in the Panel’s charter and
specified on the meeting agenda.
III. Meeting Participation
This meeting is open to the public. As
noted previously, the public may
participate in the meeting on-site, via
teleconference, webcast, and webinar.
The on-site check-in for visitors will be
held from 7:30 a.m. to 8:00 a.m. E.D.T.
IV. Registration Instructions
Beginning Monday, April 8, 2019 and
ending Monday, July 1, 2019 at 5:00
p.m. E.D.T., registration to attend the
Panel Meeting in person may be
completed online at https://cms.gov/
Regulations-and-Guidance/Guidance/
FACA/AdvisoryPanelonClinical
VerDate Sep<11>2014
17:22 Mar 29, 2019
Jkt 247001
DiagnosticLaboratoryTests.html. On this
web page, under ‘‘Panel Meetings,’’
click the ‘‘Register for July 22 through
July 23, 2019 Panel Meeting’’ link and
enter the required information. All of
the following information must be
submitted when registering:
•
•
•
•
Name
Company name
Address
Email addresses
V. Security, Building, and Parking
Guidelines
The meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. In
planning your arrival time, we
recommend allowing additional time to
clear security. We suggest that you
arrive at the CMS campus and parking
facilities between 7:00 a.m. and 8:00
a.m. E.D.T., so that you will be able to
arrive promptly at the meeting by 8:00
a.m. E.D.T. Individuals who are not
registered in advance will not be
permitted to enter the building and will
be unable to attend the meeting. We
note that the public may not enter the
CMS building earlier than 7:15 a.m.
E.D.T. (45 minutes before the convening
of the meeting).
Security measures include the
following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel. Persons without
proper identification may be denied
access to the building.
• Interior and exterior inspection of
vehicles (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Passing through a metal detector
and inspection of items brought into the
building. We note that all items brought
to CMS, whether personal or for the
purpose of demonstration or to support
a demonstration, are subject to
inspection. We cannot assume
responsibility for coordinating the
receipt, transfer, transport, storage, setup, safety, or timely arrival of any
personal belongings or items used for
demonstration or to support a
demonstration.
Frm 00068
Fmt 4703
VI. Panel Recommendations and
Discussions
The Panel’s recommendations will be
posted approximately 2 weeks after the
meeting on the CMS website at https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/
AdvisoryPanelonClinicalDiagnostic
LaboratoryTests.html.
VII. Special Accommodations
Note: Participants who do not plan to
attend the Panel meeting in person on
July 22 or 23, 2019 should not register.
No registration is required for
participants who plan to view the Panel
meeting via webcast or listen via
teleconference.
PO 00000
12257
Sfmt 4703
Individuals requiring special
accommodations must include the
request for these services during
registration.
VIII. Copies of the Charter
The Secretary’s Charter for the
Medicare Advisory Panel on Clinical
Diagnostic Laboratory Tests is available
on the CMS website at https://cms.gov/
Regulations-and-Guidance/Guidance/
FACA/AdvisoryPanelonClinical
DiagnosticLaboratoryTests.html or you
may obtain a copy of the charter by
submitting a request to the contact listed
in the FOR FURTHER INFORMATION
CONTACT section of this notice.
IX. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
Dated: March 15, 2019.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2019–06147 Filed 3–29–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1719–N]
Medicare Program; Public Meeting on
June 24, 2019 Regarding New and
Reconsidered Clinical Diagnostic
Laboratory Test Codes for the Clinical
Laboratory Fee Schedule for Calendar
Year 2020
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces a
public meeting to receive comments and
SUMMARY:
E:\FR\FM\01APN1.SGM
01APN1
12258
Federal Register / Vol. 84, No. 62 / Monday, April 1, 2019 / Notices
recommendations (including data on
which recommendations are based)
from the public on the appropriate basis
for establishing payment amounts for
new or substantially revised Healthcare
Common Procedure Coding System
(HCPCS) codes being considered for
Medicare payment under the Clinical
Laboratory Fee Schedule (CLFS) for
calendar year (CY) 2020. This meeting
also provides a forum for those who
submitted certain reconsideration
requests regarding final determinations
made last year on new test codes and for
the public to provide comment on the
requests.
The Medicare Advisory Panel on
Clinical Diagnostic Laboratory Tests
(Advisory Panel on CDLTs) will
participate in this CLFS Annual Public
Meeting by gathering information and
asking questions to presenters, and will
hold its next public meeting on July 22
and 23, 2019. The public meeting for the
Advisory Panel on CDLTs will focus on
the discussion of and recommendations
for test codes presented during the June
24, 2019 CLFS Annual Public Meeting.
The Panel meeting also will address any
other CY 2020 CLFS issues that are
designated in the Panel’s charter and
specified on the meeting agenda.
DATES:
CLFS Annual Public Meeting Date:
The meeting is scheduled for Monday,
June 24, 2019 from 8:00 a.m. to 4:30
p.m., E.D.T.)
Deadline for Registration of Presenters
and Submission of Presentations: All
presenters for the CLFS Annual Public
Meeting must register and submit their
presentations electronically to our CLFS
dedicated email box at CLFS_Annual_
Public_Meeting@cms.hhs.gov, by June
10, 2019 at 5:00 p.m. E.D.T. Any
presentations received after that date
and time will not be included in the
meeting.
Deadline for Submitting Requests for
Special Accommodations: Requests for
special accommodations must be
received no later than 5:00 p.m. E.D.T.
on June 10, 2019.
Deadline for Submission of Written
Comments Related to the CLFS Annual
Public Meeting: Written comments
regarding the presentations must be
received by July 8, 2019 at 5:00 p.m.
E.D.T. (2 weeks after the meeting).
Publication of Proposed
Determinations: We intend to publish
our proposed determinations for new
test codes and our preliminary
determinations for reconsidered codes
(as described later in this notice in
section II. ‘‘Format’’) for CY 2020 by
early September 2019.
Deadline for Submission of Written
Comments Related to Proposed
VerDate Sep<11>2014
17:22 Mar 29, 2019
Jkt 247001
Determinations: Comments in response
to the preliminary determinations will
be due by early October 2019.
Where to Submit Written Comments:
Interested parties should submit all
written comments on presentations and
preliminary determinations to the
address specified in the ADDRESSES
section of this notice or electronically to
our CLFS dedicated email box, CLFS_
Annual_Public_Meeting@cms.hhs.gov
(the specific date for the publication of
these determinations on the CMS
website, as well as the deadline for
submitting comments regarding these
determinations, will be published on
the CMS website).
ADDRESSES: The CLFS Annual Public
Meeting will be held in the main
auditorium of the Centers for Medicare
& Medicaid Services (CMS), Central
Building, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
FOR FURTHER INFORMATION CONTACT:
Rasheeda Arthur, Ph.D., (410) 786–3434.
Submit all inquiries to the CLFS
dedicated email box, CLFS_Annual_
Public_Meeting@cms.hhs.gov with the
subject entitled ‘‘CLFS Annual Public
Meeting Inquiry.’’
SUPPLEMENTARY INFORMATION:
I. Background
Section 531(b) of the Medicare,
Medicaid, and SCHIP Benefits
Improvement and Protection Act of
2000 (BIPA) (Pub. L. 106–554) required
the Secretary of the Department of
Health and Human Services (the
Secretary) to establish procedures for
coding and payment determinations for
new clinical diagnostic laboratory tests
under Part B of title XVIII of the Social
Security Act (the Act) that permit public
consultation in a manner consistent
with the procedures established for
implementing coding modifications for
International Classification of Diseases
(ICD–9–CM) (now, ICD–10–CM). The
procedures and Clinical Laboratory Fee
Schedule (CLFS) public meeting
announced in this notice for new tests
are in accordance with the procedures
published on November 23, 2001 in the
Federal Register (66 FR 58743) to
implement section 531(b) of BIPA.
Section 942(b) of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub.
L. 108–173) added section 1833(h)(8) of
the Act. Section 1833(h)(8)(A) of the Act
requires the Secretary to establish by
regulation procedures for determining
the basis for, and amount of, payment
for any clinical diagnostic laboratory
test for which a new or substantially
revised Healthcare Common Procedure
Coding System (HCPCS) code is
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
assigned on or after January 1, 2005
(hereinafter referred to as ‘‘new tests’’).
A code is considered to be substantially
revised if there is a substantive change
to the definition of the test or procedure
to which the code applies (such as, a
new analyte or a new methodology for
measuring an existing analyte-specific
test). (See section 1833(h)(8)(E)(ii) of the
Act and 42 CFR 414.502).
Section 1833(h)(8)(B) of the Act sets
forth the process for determining the
basis for, and the amount of, payment
for new tests. Pertinent to this notice,
sections 1833(h)(8)(B)(i) and (ii) of the
Act require the Secretary to make
available to the public a list that
includes any such test for which
establishment of a payment amount is
being considered for a year and, on the
same day that the list is made available,
cause to have published in the Federal
Register notice of a meeting to receive
comments and recommendations
(including data on which
recommendations are based) from the
public on the appropriate basis for
establishing payment amounts for the
tests on such list. This list of codes for
which the establishment of a payment
amount under the CLFS is being
considered for CY 2020 will be posted
on the Center for Medicare & Medicaid
Services (CMS) website concurrent with
the publication of this notice and may
be updated prior to the CLFS Annual
Public Meeting. The CLFS Annual
Public Meeting list of codes can be
found on the CMS website at https://
www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/
ClinicalLabFeeSched/
index.html?redirect=/
ClinicalLabFeeSched/. Section
1833(h)(8)(B)(iii) of the Act requires that
we convene the public meeting not less
than 30 days after publication of the
notice in the Federal Register. The
CLFS requirements regarding public
consultation are codified at 42 CFR
414.506.
Two bases of payment are used to
establish payment amounts for new
clinical diagnostic laboratory tests
(CDLTs). The first basis, called
‘‘crosswalking,’’ is used when a new
CDLT is determined to be comparable to
an existing test, multiple existing test
codes, or a portion of an existing test
code. New CDLTs that were assigned
new or substantially revised codes prior
to January 1, 2018, are subject to
provisions set forth under § 414.508(a).
For a new CDLT that is assigned a new
or significantly revised code on or after
January 1, 2018, CMS assigns to the new
CDLT code the payment amount
established under § 414.507 of the
comparable existing CDLT. Payment for
E:\FR\FM\01APN1.SGM
01APN1
Federal Register / Vol. 84, No. 62 / Monday, April 1, 2019 / Notices
the new CDLT code is made at the
payment amount established under
§ 414.507. (See § 414.508(b)(1)).
The second basis called ‘‘gapfilling,’’
is used when no comparable existing
CDLT is available. When using this
method, instructions are provided to
each Medicare Administrative
Contractor (MAC) to determine a
payment amount for its Part B
geographic area for use in the first year.
In the first year, for a new CDLT that is
assigned a new or substantially revised
code on or after January 1, 2018, the
MAC-specific amounts are established
using the following sources of
information, if available: (1) Charges for
the test and routine discounts to
charges; (2) resources required to
perform the test; (3) payment amounts
determined by other payers; (4) charges,
payment amounts, and resources
required for other tests that may be
comparable or otherwise relevant; and
(5) other criteria that CMS determines
appropriate. In the second year, the test
code is paid at the median of the MACspecific amounts. (See § 414.508(b)(2)).
Under section 1833(h)(8)(B)(iv) of the
Act and § 414.506(d)(1), CMS, taking
into account the comments and
recommendations (and accompanying
data) received at the CLFS Annual
Public Meeting, develops and makes
available to the public a list of proposed
determinations with respect to the
appropriate basis for establishing a
payment amount for each code, an
explanation of the reasons for each
determination, the data on which the
determinations are based, and a request
for public written comments on the
proposed determinations. Under section
1833(h)(8)(B)(v) of the Act and
§ 414.506(d)(2), taking into account the
comments received on the proposed
determinations during the public
comment period, CMS then develops
and makes available to the public a list
of final determinations of payment
amounts for tests along with the
rationale for each determination, the
data on which the determinations are
based, and responses to comments and
suggestions received from the public.
Section 216(a) of the Protecting
Access to Medicare Act of 2014 (PAMA)
(Pub. L. 113–93) added section 1834A to
the Act. The statute requires extensive
revisions to the Medicare payment,
coding, and coverage requirements for
CDLTs. Pertinent to this notice, section
1834A(c)(3) of the Act requires the
Secretary to consider recommendations
from the expert outside advisory panel
established under section 1834A(f)(1) of
the Act when determining payment
using crosswalking or gapfilling
processes. In addition, section
VerDate Sep<11>2014
17:22 Mar 29, 2019
Jkt 247001
1834A(c)(4) of the Act requires the
Secretary to make available to the public
an explanation of the payment rates for
the new test codes, including an
explanation of how the gapfilling
criteria and panel recommendations are
applied. These requirements are
codified in § 414.506(d) and (e).
After the final determinations have
been posted on the CMS website, the
public may request reconsideration of
the basis and amount of payment for a
new CDLT as set forth in § 414.509.
Pertinent to this notice, those requesting
that CMS reconsider the basis for
payment or the payment amount as set
forth in § 414.509(a) and (b), may
present their reconsideration requests at
the following year’s CLFS Annual
Public Meeting provided the requestor
made the request to present at the CLFS
Annual Public Meeting in the written
reconsideration request. For purposes of
this notice, we refer to these codes as
the ‘‘reconsidered codes.’’ The public
may comment on the reconsideration
requests. (See the CY 2008 Physician
Fee Schedule final rule with comment
period published in the Federal
Register on November 27, 2007 (72 FR
66275 through 66280) for more
information on these procedures).
II. Format
We are following our usual process,
including an annual public meeting to
determine the appropriate basis and
payment amount for new and
reconsidered codes under the CLFS for
CY 2020.
This meeting is open to the public.
The on-site check-in for visitors will be
held from 7:30 a.m. to 8:00 a.m. E.D.T.,
followed by opening remarks.
Registered persons from the public may
discuss and make recommendations for
specific new and reconsidered codes for
the CY 2020 CLFS.
As stated in the SUMMARY section of
this notice, the Advisory Panel on
CDLTs will participate in the CLFS
Annual Public Meeting on June 24, 2019
by gathering information and asking
questions to presenters, and will hold
its own public meeting on July 22 and
23, 2019, to discuss matters of the Panel
and make recommendations regarding
the test codes presented at the CLFS
Annual Public Meeting. The
announcement for the Advisory Panel
on CDLTs meeting is included in a
separate Federal Register notice.
Due to time constraints, presentations
must be brief, lasting no longer than 10
minutes, and must be accompanied by
three written copies. In addition,
presenters should make copies available
for approximately 50 meeting
participants, since CMS will not be
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
12259
providing additional copies. Written
presentations must be electronically
submitted to CMS on or before June 10,
2019. Presentation slots will be assigned
on a first-come, first-served basis. In the
event there is not enough time for
presentations by everyone who is
interested in presenting, CMS will
accept written presentations from those
who were unable to present due to time
constraints. Presentations should be
sent via email to our CLFS dedicated
email box, CLFS_Annual_Public_
Meeting@cms.hhs.gov. In addition,
individuals may also submit requests
after the CLFS Annual Public Meeting to
obtain electronic versions of the
presentations. Requests for electronic
copies of the presentations after the
public meeting should be sent via email
to our CLFS dedicated email box, noted
above.
Presenters are required to submit all
presentations using a standard
PowerPoint template that is available on
the CMS website, at https://
www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/
ClinicalLabFeeSched/Laboratory_
Public_Meetings.html, under the
‘‘Meeting Notice and Agenda’’ heading.
For reconsidered and new codes,
presenters should address all of the
following five items:
(1) Reconsidered or new codes and
descriptor.
(2) Test purpose and method.
(3) Costs.
(4) Charges.
(5) Recommendation with rationale
for one of the two bases (crosswalking
or gapfilling) for determining payment
for reconsidered and new tests.
Additionally, presenters should
provide the data on which their
recommendations are based.
Presentations regarding reconsidered
and new test codes that do not address
the above five items for presenters may
be considered incomplete and may not
be considered by CMS when making a
determination. However, we may
request missing information following
the meeting to prevent a
recommendation from being considered
incomplete.
Taking into account the comments
and recommendations (and
accompanying data) received at the
CLFS Annual Public Meeting, we intend
to post our proposed determinations
with respect to the appropriate basis for
establishing a payment amount for each
new test code and our preliminary
determinations with respect to the
reconsidered codes along with an
explanation of the reasons for each
determination, the data on which the
determinations are based, and a request
E:\FR\FM\01APN1.SGM
01APN1
12260
Federal Register / Vol. 84, No. 62 / Monday, April 1, 2019 / Notices
for public written comments on these
determinations on the CMS website by
early September 2019. This website can
be accessed at https://www.cms.gov/
Medicare/Medicare-Fee-for-ServicePayment/ClinicalLabFeeSched/
index.html?redirect=/
ClinicalLabFeeSched/. Interested parties
may submit written comments on the
preliminary determinations for new and
reconsidered codes by early October
2019, to the address specified in the
ADDRESSES section of this notice or
electronically to our CLFS dedicated
email box, CLFS_Annual_Public_
Meeting@cms.hhs.gov (the specific date
for the publication of the determinations
on the CMS website, as well as the
deadline for submitting comments
regarding the determinations, will be
published on the CMS website). Final
determinations for new test codes to be
included for payment on the CLFS for
CY 2020 and reconsidered codes will be
posted on the CMS website in
November 2019, along with the
rationale for each determination, the
data on which the determinations are
based, and responses to comments and
suggestions received from the public.
The final determinations with respect to
reconsidered codes are not subject to
further reconsideration. With respect to
the final determinations for new test
codes, the public may request
reconsideration of the basis and amount
of payment as set forth in § 414.509.
III. Registration Instructions
The Division of Ambulatory Services
in the CMS Center for Medicare is
coordinating the CLFS Annual Public
Meeting registration. Beginning April 8,
2019, and ending June 10, 2019,
registration may be completed on-line at
https://www.cms.gov/Medicare/
Medicare-Fee-for-Service-Payment/
ClinicalLabFeeSched/
index.html?redirect=/
ClinicalLabFeeSched/. On this web
page, under the heading ‘‘Meeting
Notice, Registration and Agenda,’’ you
will find a link entitled ‘‘Register for
CLFS Annual Meeting’’. Click this link
and enter the required information. All
the following information must be
submitted when registering:
• Name.
• Company name.
• Address.
• Telephone numbers.
• Email addresses.
When registering, individuals who
want to make a presentation must also
specify the new test codes on which
they will be presenting comments. A
confirmation will be sent upon receipt
of the registration. Individuals must
register by the date specified in the
VerDate Sep<11>2014
17:22 Mar 29, 2019
Jkt 247001
DATES section of this notice. Registration
is only required for individuals
attending the meeting in person.
If not attending the CLFS Annual
Public Meeting in person, the public
may view the meeting via webcast or
listen by teleconference. During the
public meeting, webcasting is accessible
online at https://cms.gov/live.
Teleconference dial-in information will
appear on the final CLFS Annual Public
Meeting agenda, which will be posted
on the CMS website when available at
https://www.cms.gov/Medicare/
Medicare-Fee-for-Service-Payment/
ClinicalLabFeeSched/
index.html?redirect=/
ClinicalLabFeeSched/.
IV. Security, Building, and Parking
Guidelines
The meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. In
planning your arrival time, we
recommend allowing additional time to
clear security. We suggest that you
arrive at the CMS campus and parking
facilities between 7:00 a.m. and 8:00
a.m. E.D.T., so that you will be able to
arrive promptly at the meeting by 8:00
a.m. E.D.T. Individuals who are not
registered in advance will not be
permitted to enter the building and will
be unable to attend the meeting. We
note that the public may not enter the
CMS building earlier than 7:15 a.m.
E.D.T. (45 minutes before the convening
of the meeting).
Security measures include the
following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel. Persons without
proper identification may be denied
access to the building.
• Interior and exterior inspection of
vehicles (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Passing through a metal detector
and inspection of items brought into the
building. We note that all items brought
to CMS, whether personal or for the
purpose of demonstration or to support
a demonstration, are subject to
inspection. We cannot assume
responsibility for coordinating the
receipt, transfer, transport, storage, setup, safety, or timely arrival of any
personal belongings or items used for
demonstration or to support a
demonstration.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
V. Special Accommodations
Individuals attending the meeting
who are hearing or visually impaired
and have special requirements, or a
condition that requires special
assistance, should provide that
information upon registering for the
meeting. The deadline for registration is
listed in the DATES section of this notice.
VI. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
Dated: March 15, 2019.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2019–06148 Filed 3–29–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3369–FN]
Medicare and Medicaid Programs:
Application From the American
Association for Accreditation of
Ambulatory Surgery Facilities, Inc.
(AAAASF) for Its Outpatient Physical
Therapy and Speech Language
Pathology Services Accreditation
Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final notice.
AGENCY:
This final notice announces
our decision to approve the American
Association for Accreditation of
Ambulatory Surgery Facilities, Inc.
(AAAASF) for continued recognition as
a national accrediting organization for
clinics, rehabilitation agencies, or
public health agencies that furnish
outpatient physical therapy and speech
language pathology services that wish to
participate in the Medicare or Medicaid
programs.
DATES: The approval announced in this
notice is effective on April 4, 2019
through April 4, 2025.
FOR FURTHER INFORMATION CONTACT: Erin
Imhoff, (410) 786–2337; Monda Shaver,
(410) 786–3410; or Tara Lemons, (410)
786–3030.
SUMMARY:
E:\FR\FM\01APN1.SGM
01APN1
]]>Agencies
[Federal Register Volume 84, Number 62 (Monday, April 1, 2019)]
[Notices]
[Pages 12257-12260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06148]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1719-N]
Medicare Program; Public Meeting on June 24, 2019 Regarding New
and Reconsidered Clinical Diagnostic Laboratory Test Codes for the
Clinical Laboratory Fee Schedule for Calendar Year 2020
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting to receive comments and
[[Page 12258]]
recommendations (including data on which recommendations are based)
from the public on the appropriate basis for establishing payment
amounts for new or substantially revised Healthcare Common Procedure
Coding System (HCPCS) codes being considered for Medicare payment under
the Clinical Laboratory Fee Schedule (CLFS) for calendar year (CY)
2020. This meeting also provides a forum for those who submitted
certain reconsideration requests regarding final determinations made
last year on new test codes and for the public to provide comment on
the requests.
The Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests
(Advisory Panel on CDLTs) will participate in this CLFS Annual Public
Meeting by gathering information and asking questions to presenters,
and will hold its next public meeting on July 22 and 23, 2019. The
public meeting for the Advisory Panel on CDLTs will focus on the
discussion of and recommendations for test codes presented during the
June 24, 2019 CLFS Annual Public Meeting. The Panel meeting also will
address any other CY 2020 CLFS issues that are designated in the
Panel's charter and specified on the meeting agenda.
DATES:
CLFS Annual Public Meeting Date: The meeting is scheduled for
Monday, June 24, 2019 from 8:00 a.m. to 4:30 p.m., E.D.T.)
Deadline for Registration of Presenters and Submission of
Presentations: All presenters for the CLFS Annual Public Meeting must
register and submit their presentations electronically to our CLFS
dedicated email box at [email protected], by June
10, 2019 at 5:00 p.m. E.D.T. Any presentations received after that date
and time will not be included in the meeting.
Deadline for Submitting Requests for Special Accommodations:
Requests for special accommodations must be received no later than 5:00
p.m. E.D.T. on June 10, 2019.
Deadline for Submission of Written Comments Related to the CLFS
Annual Public Meeting: Written comments regarding the presentations
must be received by July 8, 2019 at 5:00 p.m. E.D.T. (2 weeks after the
meeting).
Publication of Proposed Determinations: We intend to publish our
proposed determinations for new test codes and our preliminary
determinations for reconsidered codes (as described later in this
notice in section II. ``Format'') for CY 2020 by early September 2019.
Deadline for Submission of Written Comments Related to Proposed
Determinations: Comments in response to the preliminary determinations
will be due by early October 2019.
Where to Submit Written Comments: Interested parties should submit
all written comments on presentations and preliminary determinations to
the address specified in the ADDRESSES section of this notice or
electronically to our CLFS dedicated email box,
[email protected] (the specific date for the
publication of these determinations on the CMS website, as well as the
deadline for submitting comments regarding these determinations, will
be published on the CMS website).
ADDRESSES: The CLFS Annual Public Meeting will be held in the main
auditorium of the Centers for Medicare & Medicaid Services (CMS),
Central Building, 7500 Security Boulevard, Baltimore, Maryland 21244-
1850.
FOR FURTHER INFORMATION CONTACT: Rasheeda Arthur, Ph.D., (410) 786-
3434. Submit all inquiries to the CLFS dedicated email box,
[email protected] with the subject entitled ``CLFS
Annual Public Meeting Inquiry.''
SUPPLEMENTARY INFORMATION:
I. Background
Section 531(b) of the Medicare, Medicaid, and SCHIP Benefits
Improvement and Protection Act of 2000 (BIPA) (Pub. L. 106-554)
required the Secretary of the Department of Health and Human Services
(the Secretary) to establish procedures for coding and payment
determinations for new clinical diagnostic laboratory tests under Part
B of title XVIII of the Social Security Act (the Act) that permit
public consultation in a manner consistent with the procedures
established for implementing coding modifications for International
Classification of Diseases (ICD-9-CM) (now, ICD-10-CM). The procedures
and Clinical Laboratory Fee Schedule (CLFS) public meeting announced in
this notice for new tests are in accordance with the procedures
published on November 23, 2001 in the Federal Register (66 FR 58743) to
implement section 531(b) of BIPA.
Section 942(b) of the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub. L. 108-173) added section
1833(h)(8) of the Act. Section 1833(h)(8)(A) of the Act requires the
Secretary to establish by regulation procedures for determining the
basis for, and amount of, payment for any clinical diagnostic
laboratory test for which a new or substantially revised Healthcare
Common Procedure Coding System (HCPCS) code is assigned on or after
January 1, 2005 (hereinafter referred to as ``new tests''). A code is
considered to be substantially revised if there is a substantive change
to the definition of the test or procedure to which the code applies
(such as, a new analyte or a new methodology for measuring an existing
analyte-specific test). (See section 1833(h)(8)(E)(ii) of the Act and
42 CFR 414.502).
Section 1833(h)(8)(B) of the Act sets forth the process for
determining the basis for, and the amount of, payment for new tests.
Pertinent to this notice, sections 1833(h)(8)(B)(i) and (ii) of the Act
require the Secretary to make available to the public a list that
includes any such test for which establishment of a payment amount is
being considered for a year and, on the same day that the list is made
available, cause to have published in the Federal Register notice of a
meeting to receive comments and recommendations (including data on
which recommendations are based) from the public on the appropriate
basis for establishing payment amounts for the tests on such list. This
list of codes for which the establishment of a payment amount under the
CLFS is being considered for CY 2020 will be posted on the Center for
Medicare & Medicaid Services (CMS) website concurrent with the
publication of this notice and may be updated prior to the CLFS Annual
Public Meeting. The CLFS Annual Public Meeting list of codes can be
found on the CMS website at https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/?redirect=/ClinicalLabFeeSched/. Section 1833(h)(8)(B)(iii) of the Act requires
that we convene the public meeting not less than 30 days after
publication of the notice in the Federal Register. The CLFS
requirements regarding public consultation are codified at 42 CFR
414.506.
Two bases of payment are used to establish payment amounts for new
clinical diagnostic laboratory tests (CDLTs). The first basis, called
``crosswalking,'' is used when a new CDLT is determined to be
comparable to an existing test, multiple existing test codes, or a
portion of an existing test code. New CDLTs that were assigned new or
substantially revised codes prior to January 1, 2018, are subject to
provisions set forth under Sec. 414.508(a). For a new CDLT that is
assigned a new or significantly revised code on or after January 1,
2018, CMS assigns to the new CDLT code the payment amount established
under Sec. 414.507 of the comparable existing CDLT. Payment for
[[Page 12259]]
the new CDLT code is made at the payment amount established under Sec.
414.507. (See Sec. 414.508(b)(1)).
The second basis called ``gapfilling,'' is used when no comparable
existing CDLT is available. When using this method, instructions are
provided to each Medicare Administrative Contractor (MAC) to determine
a payment amount for its Part B geographic area for use in the first
year. In the first year, for a new CDLT that is assigned a new or
substantially revised code on or after January 1, 2018, the MAC-
specific amounts are established using the following sources of
information, if available: (1) Charges for the test and routine
discounts to charges; (2) resources required to perform the test; (3)
payment amounts determined by other payers; (4) charges, payment
amounts, and resources required for other tests that may be comparable
or otherwise relevant; and (5) other criteria that CMS determines
appropriate. In the second year, the test code is paid at the median of
the MAC-specific amounts. (See Sec. 414.508(b)(2)).
Under section 1833(h)(8)(B)(iv) of the Act and Sec. 414.506(d)(1),
CMS, taking into account the comments and recommendations (and
accompanying data) received at the CLFS Annual Public Meeting, develops
and makes available to the public a list of proposed determinations
with respect to the appropriate basis for establishing a payment amount
for each code, an explanation of the reasons for each determination,
the data on which the determinations are based, and a request for
public written comments on the proposed determinations. Under section
1833(h)(8)(B)(v) of the Act and Sec. 414.506(d)(2), taking into
account the comments received on the proposed determinations during the
public comment period, CMS then develops and makes available to the
public a list of final determinations of payment amounts for tests
along with the rationale for each determination, the data on which the
determinations are based, and responses to comments and suggestions
received from the public.
Section 216(a) of the Protecting Access to Medicare Act of 2014
(PAMA) (Pub. L. 113-93) added section 1834A to the Act. The statute
requires extensive revisions to the Medicare payment, coding, and
coverage requirements for CDLTs. Pertinent to this notice, section
1834A(c)(3) of the Act requires the Secretary to consider
recommendations from the expert outside advisory panel established
under section 1834A(f)(1) of the Act when determining payment using
crosswalking or gapfilling processes. In addition, section 1834A(c)(4)
of the Act requires the Secretary to make available to the public an
explanation of the payment rates for the new test codes, including an
explanation of how the gapfilling criteria and panel recommendations
are applied. These requirements are codified in Sec. 414.506(d) and
(e).
After the final determinations have been posted on the CMS website,
the public may request reconsideration of the basis and amount of
payment for a new CDLT as set forth in Sec. 414.509. Pertinent to this
notice, those requesting that CMS reconsider the basis for payment or
the payment amount as set forth in Sec. 414.509(a) and (b), may
present their reconsideration requests at the following year's CLFS
Annual Public Meeting provided the requestor made the request to
present at the CLFS Annual Public Meeting in the written
reconsideration request. For purposes of this notice, we refer to these
codes as the ``reconsidered codes.'' The public may comment on the
reconsideration requests. (See the CY 2008 Physician Fee Schedule final
rule with comment period published in the Federal Register on November
27, 2007 (72 FR 66275 through 66280) for more information on these
procedures).
II. Format
We are following our usual process, including an annual public
meeting to determine the appropriate basis and payment amount for new
and reconsidered codes under the CLFS for CY 2020.
This meeting is open to the public. The on-site check-in for
visitors will be held from 7:30 a.m. to 8:00 a.m. E.D.T., followed by
opening remarks. Registered persons from the public may discuss and
make recommendations for specific new and reconsidered codes for the CY
2020 CLFS.
As stated in the SUMMARY section of this notice, the Advisory Panel
on CDLTs will participate in the CLFS Annual Public Meeting on June 24,
2019 by gathering information and asking questions to presenters, and
will hold its own public meeting on July 22 and 23, 2019, to discuss
matters of the Panel and make recommendations regarding the test codes
presented at the CLFS Annual Public Meeting. The announcement for the
Advisory Panel on CDLTs meeting is included in a separate Federal
Register notice.
Due to time constraints, presentations must be brief, lasting no
longer than 10 minutes, and must be accompanied by three written
copies. In addition, presenters should make copies available for
approximately 50 meeting participants, since CMS will not be providing
additional copies. Written presentations must be electronically
submitted to CMS on or before June 10, 2019. Presentation slots will be
assigned on a first-come, first-served basis. In the event there is not
enough time for presentations by everyone who is interested in
presenting, CMS will accept written presentations from those who were
unable to present due to time constraints. Presentations should be sent
via email to our CLFS dedicated email box,
[email protected]. In addition, individuals may
also submit requests after the CLFS Annual Public Meeting to obtain
electronic versions of the presentations. Requests for electronic
copies of the presentations after the public meeting should be sent via
email to our CLFS dedicated email box, noted above.
Presenters are required to submit all presentations using a
standard PowerPoint template that is available on the CMS website, at
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Laboratory_Public_Meetings.html, under the
``Meeting Notice and Agenda'' heading.
For reconsidered and new codes, presenters should address all of
the following five items:
(1) Reconsidered or new codes and descriptor.
(2) Test purpose and method.
(3) Costs.
(4) Charges.
(5) Recommendation with rationale for one of the two bases
(crosswalking or gapfilling) for determining payment for reconsidered
and new tests.
Additionally, presenters should provide the data on which their
recommendations are based. Presentations regarding reconsidered and new
test codes that do not address the above five items for presenters may
be considered incomplete and may not be considered by CMS when making a
determination. However, we may request missing information following
the meeting to prevent a recommendation from being considered
incomplete.
Taking into account the comments and recommendations (and
accompanying data) received at the CLFS Annual Public Meeting, we
intend to post our proposed determinations with respect to the
appropriate basis for establishing a payment amount for each new test
code and our preliminary determinations with respect to the
reconsidered codes along with an explanation of the reasons for each
determination, the data on which the determinations are based, and a
request
[[Page 12260]]
for public written comments on these determinations on the CMS website
by early September 2019. This website can be accessed at https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/?redirect=/ClinicalLabFeeSched/.
Interested parties may submit written comments on the preliminary
determinations for new and reconsidered codes by early October 2019, to
the address specified in the ADDRESSES section of this notice or
electronically to our CLFS dedicated email box,
[email protected] (the specific date for the
publication of the determinations on the CMS website, as well as the
deadline for submitting comments regarding the determinations, will be
published on the CMS website). Final determinations for new test codes
to be included for payment on the CLFS for CY 2020 and reconsidered
codes will be posted on the CMS website in November 2019, along with
the rationale for each determination, the data on which the
determinations are based, and responses to comments and suggestions
received from the public. The final determinations with respect to
reconsidered codes are not subject to further reconsideration. With
respect to the final determinations for new test codes, the public may
request reconsideration of the basis and amount of payment as set forth
in Sec. 414.509.
III. Registration Instructions
The Division of Ambulatory Services in the CMS Center for Medicare
is coordinating the CLFS Annual Public Meeting registration. Beginning
April 8, 2019, and ending June 10, 2019, registration may be completed
on-line at https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/?redirect=/ClinicalLabFeeSched/.
On this web page, under the heading ``Meeting Notice, Registration and
Agenda,'' you will find a link entitled ``Register for CLFS Annual
Meeting''. Click this link and enter the required information. All the
following information must be submitted when registering:
Name.
Company name.
Address.
Telephone numbers.
Email addresses.
When registering, individuals who want to make a presentation must
also specify the new test codes on which they will be presenting
comments. A confirmation will be sent upon receipt of the registration.
Individuals must register by the date specified in the DATES section of
this notice. Registration is only required for individuals attending
the meeting in person.
If not attending the CLFS Annual Public Meeting in person, the
public may view the meeting via webcast or listen by teleconference.
During the public meeting, webcasting is accessible online at https://cms.gov/live. Teleconference dial-in information will appear on the
final CLFS Annual Public Meeting agenda, which will be posted on the
CMS website when available at https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/?redirect=/ClinicalLabFeeSched/.
IV. Security, Building, and Parking Guidelines
The meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. In planning your
arrival time, we recommend allowing additional time to clear security.
We suggest that you arrive at the CMS campus and parking facilities
between 7:00 a.m. and 8:00 a.m. E.D.T., so that you will be able to
arrive promptly at the meeting by 8:00 a.m. E.D.T. Individuals who are
not registered in advance will not be permitted to enter the building
and will be unable to attend the meeting. We note that the public may
not enter the CMS building earlier than 7:15 a.m. E.D.T. (45 minutes
before the convening of the meeting).
Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel. Persons without proper identification may be denied access
to the building.
Interior and exterior inspection of vehicles (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and instructions will be issued after the vehicle
inspection.
Passing through a metal detector and inspection of items
brought into the building. We note that all items brought to CMS,
whether personal or for the purpose of demonstration or to support a
demonstration, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set-up, safety, or timely arrival of any personal belongings
or items used for demonstration or to support a demonstration.
V. Special Accommodations
Individuals attending the meeting who are hearing or visually
impaired and have special requirements, or a condition that requires
special assistance, should provide that information upon registering
for the meeting. The deadline for registration is listed in the DATES
section of this notice.
VI. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
Dated: March 15, 2019.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2019-06148 Filed 3-29-19; 8:45 am]
BILLING CODE 4120-01-P
